91黑料网

In-person class cancellation and work-from-home / Annulation des cours en pr茅sentiel et t茅l茅travail

Updated: Tue, 03/10/2026 - 17:14
In-person class cancellation and work-from-home / Annulation des cours en pr茅sentiel et t茅l茅travail. McGILL ALERT! Due to freezing rain all in-person classes and activities on Wednesday, March 11, will be cancelled. Staff are asked not to come to campus tomorrow unless they are required on site by their supervisor to perform necessary functions and activities. See your 91黑料网 email for more information.
...
ALERTE McGILL! En raison de la pluie vergla莽ante, tous les cours et activit茅s en pr茅sentiel pr茅vus pour le mercredi 11 mars sont annul茅s. Nous demandons au personnel de ne pas se pr茅senter sur le campus demain, 脿 moins que leur superviseur ne leur demande d鈥櫭猼re sur place pour accomplir des fonctions ou activit茅s n茅cessaires au fonctionnement du campus. Pour plus d鈥檌nformations, veuillez consulter vos courriels de 91黑料网.
Home / Scientifiques / Chercheurs et chercheuses D2R

Benoit Gentil

Academic title(s): 

Associate Professor

Benoit Gentil
Branch: 
Universit茅 91黑料网
Department: 
Kin茅siologie et 茅ducation physique
Areas of expertise: 
  • Gene Therapy
  • Neuropathies
  • Cellular and Animal Models
  • ARSACS
  • Molecular Portraits of Athletes
Biography: 

Benoit J. Gentil, Ph.D. is Associate Professor in the Department of Kinesiology and Physical Education and Interim Director of the Sylvan Adams Sports Science Institute at 91黑料网. His research focuses on the genetics and epigenetics of motor development, neuromuscular disorders, and athletic performance. He studies how gene variants and epigenetic changes, particularly those affecting chromatin structure, influence neuronal and muscle function during postnatal development. His work spans three areas: (1) basic research on gene-environment interactions; (2) pre-clinical strategies for treating rare motor disorders such as ARSACS and Charcot-Marie-Tooth; and (3) applied research identifying gene markers linked to motor delays, athletic ability, and gene doping. Using cellular and animal models, his lab develops personalized therapeutic and enhancement strategies. Dr. Gentil has published in leading journals such as FASEB Journal, Cells, and Human Molecular Genetics, and actively teaches and supervises students while serving on national and international scientific advisory boards.

Link(s): 
Benoit Gentil, 91黑料网
Projects: 

Principal Investigator:聽

Commercialization Priming | Conversion of a gene therapy into an RNA therapy using a novel nanoparticle system (or Collaboration with QurCan Therapeutics to develop an RNA therapy to treat a genetic brain disease)

Back to top